JP2023508142A5 - - Google Patents

Info

Publication number
JP2023508142A5
JP2023508142A5 JP2022538727A JP2022538727A JP2023508142A5 JP 2023508142 A5 JP2023508142 A5 JP 2023508142A5 JP 2022538727 A JP2022538727 A JP 2022538727A JP 2022538727 A JP2022538727 A JP 2022538727A JP 2023508142 A5 JP2023508142 A5 JP 2023508142A5
Authority
JP
Japan
Prior art keywords
methyl
acrylic acid
oxadiazole
phenyl
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022538727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508142A (ja
JP7679384B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2020/053357 external-priority patent/WO2021130492A1/en
Publication of JP2023508142A publication Critical patent/JP2023508142A/ja
Publication of JP2023508142A5 publication Critical patent/JP2023508142A5/ja
Priority to JP2025077120A priority Critical patent/JP2025131581A/ja
Application granted granted Critical
Publication of JP7679384B2 publication Critical patent/JP7679384B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022538727A 2019-12-23 2020-12-23 抗炎症特性を有するカルボン酸誘導体 Active JP7679384B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025077120A JP2025131581A (ja) 2019-12-23 2025-05-07 抗炎症特性を有するカルボン酸誘導体

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP19219531.1 2019-12-23
EP19219531 2019-12-23
EP20162545.6 2020-03-11
EP20162545 2020-03-11
EP20189623 2020-08-05
EP20189623.0 2020-08-05
EP20205768 2020-11-04
EP20205768.3 2020-11-04
PCT/GB2020/053357 WO2021130492A1 (en) 2019-12-23 2020-12-23 Carboxy derivatives with antiinflammatory properties

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025077120A Division JP2025131581A (ja) 2019-12-23 2025-05-07 抗炎症特性を有するカルボン酸誘導体

Publications (3)

Publication Number Publication Date
JP2023508142A JP2023508142A (ja) 2023-03-01
JP2023508142A5 true JP2023508142A5 (https=) 2023-12-22
JP7679384B2 JP7679384B2 (ja) 2025-05-19

Family

ID=74104118

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022538727A Active JP7679384B2 (ja) 2019-12-23 2020-12-23 抗炎症特性を有するカルボン酸誘導体
JP2025077120A Pending JP2025131581A (ja) 2019-12-23 2025-05-07 抗炎症特性を有するカルボン酸誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025077120A Pending JP2025131581A (ja) 2019-12-23 2025-05-07 抗炎症特性を有するカルボン酸誘導体

Country Status (29)

Country Link
EP (2) EP4081511B3 (https=)
JP (2) JP7679384B2 (https=)
KR (1) KR20220119425A (https=)
CN (1) CN115066418B (https=)
AU (1) AU2020412853A1 (https=)
BR (1) BR112022011933A2 (https=)
CA (2) CA3161424C (https=)
CL (1) CL2022001722A1 (https=)
CO (1) CO2022008652A2 (https=)
CR (1) CR20220300A (https=)
DK (1) DK4081511T3 (https=)
EC (1) ECSP22049370A (https=)
ES (1) ES2987014T3 (https=)
FI (1) FI4081511T3 (https=)
HR (1) HRP20241378T1 (https=)
HU (1) HUE068571T2 (https=)
IL (1) IL293982B2 (https=)
JO (1) JOP20220162A1 (https=)
LT (1) LT4081511T (https=)
MA (1) MA58170B1 (https=)
MD (1) MD4081511T2 (https=)
MX (1) MX2022007846A (https=)
PE (1) PE20221584A1 (https=)
PH (1) PH12022551546A1 (https=)
PL (1) PL4081511T4 (https=)
RS (1) RS66019B1 (https=)
SI (1) SI4081511T1 (https=)
TW (1) TWI891696B (https=)
WO (1) WO2021130492A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021013299A (es) 2019-04-30 2022-01-31 Sitryx Therapeutics Ltd Derivados de acido itaconico y usos de estos en el tratamiento de una enfermedad inflamatoria asociada con una respuesta inmunitaria indeseable.
WO2020232247A1 (en) 2019-05-14 2020-11-19 Provention Bio, Inc. Methods and compositions for preventing type 1 diabetes
IL298999A (en) 2020-06-11 2023-02-01 Provention Bio Inc Methods and compositions for the prevention of type 1 diabetes
EP4192821A1 (en) 2020-08-05 2023-06-14 Sitryx Therapeutics Limited Alpha,beta unsaturated methacrylic esters with anti-inflammatory properties
EP4330231A1 (en) * 2021-04-26 2024-03-06 Sitryx Therapeutics Limited 2-methylene-4-oxo-butanoic acid drivatives for the treatment of inflammation
JP2024520444A (ja) 2021-05-24 2024-05-24 プロヴェンション・バイオ・インコーポレイテッド 1型糖尿病を治療するための方法
EP4359390A1 (en) * 2021-06-22 2024-05-01 Sitryx Therapeutics Limited Acrylamide derivatives useful as anti-inflammatory agents
CN113499453B (zh) * 2021-07-20 2022-10-21 徐州医科大学 自噬抑制及抗炎联合温合光热诊疗剂及其制备方法与应用
US20240360067A1 (en) 2021-08-11 2024-10-31 Sitryx Therapeutics Limited Derivatives of itaconic acid and their use as anti-inflammatory agents
AU2023287566A1 (en) 2022-06-22 2025-01-16 Sitryx Therapeutics Limited Oxadiazole derivatives, preparation process thereof and their use in treating inflammatory diseases
WO2024089421A1 (en) 2022-10-25 2024-05-02 Sitryx Therapeutics Limited Tetrazole derivatives
CN120712258A (zh) 2022-12-15 2025-09-26 西特瑞治疗有限公司 用于治疗或预防炎性疾病或与不良免疫反应相关的疾病的取代吡啶类化合物
KR102864655B1 (ko) * 2023-01-19 2025-09-29 대한민국 뎅기바이러스 감염에 의한 질환의 예방 또는 치료용 약학적 조성물
CN115819186B (zh) * 2023-02-14 2023-05-16 广东银珠医药科技有限公司 一种3,5-二氯苯甲醇的新型制备方法
CN117205194A (zh) * 2023-05-10 2023-12-12 苏州大学 衣康酸或其衍生物在制备预防或治疗急性移植物抗宿主病药物中的应用
CN116725998A (zh) * 2023-07-20 2023-09-12 中国科学技术大学 特立氟胺在抑制nlrp3炎症小体活化中的应用
CN119792264B (zh) * 2025-03-14 2025-06-10 华中科技大学同济医学院附属同济医院 丁酰肼在制备预防或治疗copd的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011235A1 (en) * 1993-10-20 1995-04-27 The Upjohn Company Pyrimidinones as antiarthritic and anti-inflammatories
US6566384B1 (en) * 1996-08-07 2003-05-20 Darwin Discovery Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
TW201206429A (en) * 2010-07-08 2012-02-16 Merck Serono Sa Substituted oxadiazole derivatives
KR101861883B1 (ko) * 2010-12-06 2018-05-28 글락소 그룹 리미티드 Lp-PLA₂에 의해 매개되는 질환 또는 상태의 치료에 사용하기 위한 피리미디논 화합물
KR102085557B1 (ko) 2013-03-14 2020-03-06 엘커메스 파마 아일랜드 리미티드 푸마레이트의 프로드럭 및 다양한 질환을 치료하는데 있어서의 이들의 용도
WO2014152263A1 (en) * 2013-03-15 2014-09-25 Karyopharm Therapeutics Inc. Exo olefin-containing nuclear transport modulators and uses thereof
AU2014290368B2 (en) * 2013-07-18 2019-07-11 Baylor College Of Medicine Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
CN103923105B (zh) * 2014-04-17 2016-08-24 北京大学 2-中氮茚甲酰胺类化合物及其制备和用途
EP3416634A4 (en) 2016-02-15 2019-10-09 Artyomov, Maxim IMMUNOMODULATORY AGENTS AND METHOD FOR USE THEREOF
WO2019036509A1 (en) 2017-08-14 2019-02-21 Washington University METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH CANCER, INFLAMMATION OR IMMUNE RESPONSE
CN110731955B (zh) 2019-10-28 2023-05-02 中山大学 衣康酸二甲酯在预防和治疗溃疡性结肠炎及其癌变中的应用

Similar Documents

Publication Publication Date Title
JP2023508142A5 (https=)
HRP20241378T1 (hr) Karboksi derivati s protuupalnim svojstvima
JP2022530985A5 (https=)
JP6454448B2 (ja) 4−アミノ−2−(1H−ピラゾロ[3,4−b]ピリジン−3−イル)−6−オキソ−6,7−ジヒドロ−5H−ピロロ[2,3−d]ピリミジン誘導体及び心血管疾患を治療するためのcGMPモジュレーターとしてのそれぞれの(1H−インダゾール−3−イル)誘導体
JP2022530985A (ja) 炎症性疾患または望ましくない免疫応答に関連する疾患の治療におけるイタコン酸誘導体およびその使用
CN115884810A (zh) 作为il-17调节剂的咪唑并哒嗪
RU2010153578A (ru) Иммуноглобулины с двойными вариабельными доменами и их применение
RU2010153580A (ru) Иммуноглобулины с двумя вариабельными доменами и их применение
RU2012121189A (ru) Иммуноглобулины с двумя вариабельными доменами и их применение
RU2012119756A (ru) Иммуноглобулины с двумя вариабельными доменами и их применение
JP2021501781A5 (https=)
RU2014125220A (ru) Белки, связывающие интерлейкин-1
RU2012112550A (ru) Иммуноглобулины с двумя вариабельными доменами и их применение
RU2013133811A (ru) Иммуноглобулины с двойными вариабельными доменами и их применения
RU2015143833A (ru) СВЯЗЫВАЮЩИЕ БЕЛКИ С ДВОЙНОЙ СПЕЦИФИЧНОСТЬЮ, НАПРАВЛЕННЫЕ ПРОТИВ TNFα
RU2013109275A (ru) Иммуноглобулины с двумя вариабельными доменами и их применение
TW202227389A (zh) 新穎化合物
WO2022029438A1 (en) Alpha,beta unsaturated methacrylic esters with anti-inflammatory properties
TW201536774A (zh) 經取代之四氫咔唑及咔唑甲醯胺化合物
US20230399289A1 (en) Itaconic acid derivatives
JP2024534111A5 (https=)
CN115867348A (zh) 作为il-17调节剂的咪唑并嘧啶
EP4330231A1 (en) 2-methylene-4-oxo-butanoic acid drivatives for the treatment of inflammation
CN115768754B (zh) 调节nlrp3炎症小体通路的二氢噁唑和硫脲或脲衍生物
JP2025541281A (ja) 炎症性疾患若しくは望ましくない免疫応答に関連する疾患の治療又は予防に使用するための置換ピリジン